PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 6545391

Craniofacial dysmorphism and opsoclonus.

J R Coppeto·M L Monteiro
View original source ↗Export metadata ↓

Abstract

Report of a case with craniofacial dysmorphism and opsoclonus. The opsoclonus commenced in the perinatal period and abated at 18 months. Previous cases of opsoclonus associated with cranial and facial anomalies are reviewed, and it is suggested that opsoclonus in the authors' case was related to the delayed maturation of inhibitory cells in the brainstem.

Explore related subjects

Eye DiseasesEye MovementsFacial BonesFemaleFollow-Up StudiesHumansInfant, NewbornMaleSaccadesSkullCase ReportsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J R Coppeto, M L Monteiro. 1984. Craniofacial dysmorphism and opsoclonus.. https://doi.org/10.3109/13816818409006114

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Uses and complications of mitomycin C in ophthalmology.

Mitomycin C is a chemotherapeutic agent that acts by inhibiting DNA synthesis. Its use and application in ophthalmology has been increasing in recent years because of its modulatory effects on wound healing. Current applications include pterygium surgery, glaucoma surgery, corneal refractive surgery, cicatricial eye disease, conjunctival neoplasia and allergic eye disease. Although it has been used successfully in these conditions, it has also been associated with significant complications. This article reviews the current trends and uses of mitomycin C in the eye and its reported complications.

Eye Diseases↗